Cirrhosis, Liver
197
47
63
62
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
11 trials with published results (6%)
Research Maturity
62 completed trials (31% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.6%
7 terminated out of 197 trials
89.9%
+3.3% vs benchmark
11%
21 trials in Phase 3/4
18%
11 of 62 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 62 completed trials
Clinical Trials (197)
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
Measuring Patient Reported Needs in Outpatient Liver Disease Management
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
DELIVER Study in a Population With Clinical Suspicion of Liver Cirrhosis
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Erlotinib for Hepatocellular Carcinoma Chemoprevention
Angiotensin 2 for AKI After OLT
Chronic Hepatitis B Virus Infection in Zambia
Patients With Primary Biliary Cholangitis(PBC)
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal Bleeding
Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
4beta-hydroxycholesterol in Cirrhosis